Engineered immune cells target deadly brain tumors in children
Disease control
Recruiting now
This study tests a new treatment called BCB-276 for children and young adults with diffuse intrinsic pontine glioma (DIPG), a rare and aggressive brain tumor. BCB-276 is made from a patient's own immune cells, which are modified in a lab to recognize and attack the cancer. The tr…
Phase: PHASE2 • Sponsor: BrainChild Bio, Inc • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC